Utah Medical Products Inc
UTMD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000706698
No open-market purchases or sales by Utah Medical Products Inc insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $159.9M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Utah Medical Products Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 101 | 1 | 110 | +10 |
| Shares | 2.42M | 196.9K | 2.41M | +183.7K (+8.3%) |
| Value | $162.1M | $13.2M | $161.2M | +$12.2M (+8.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Utah Medical Products Inc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 180,095 | $12.1M | 0.00% |
| Arrowstreet Capital, Limited Partnership | 5,924 | $396.4K | 0.00% |
| Marshall Wace, LLP | 4,831 | $323.2K | 0.00% |
| Exchange Traded Concepts, LLC | 4,549 | $304.4K | 0.01% |
| Engineers Gate Manager LP | 4,308 | $288.2K | 0.01% |
| Gsa Capital Partners LLP | 3,455 | $231.0K | 0.02% |
| SEI Investments Co | 3,350 | $224.1K | 0.00% |
| Virtu Financial LLC | 3,088 | $207.0K | 0.01% |
| Copeland Capital Management, LLC | 794 | $53.1K | 0.00% |
| Northwest Financial Advisors | 300 | $20.1K | 0.02% |
| Harbor Capital Advisors, Inc. | 91 | $6.00K | 0.00% |
| Harbour Investments, Inc. | 78 | $5.22K | 0.00% |
| Venturi Wealth Management, LLC | 78 | $5.22K | 0.00% |
| GAMMA Investing LLC | 29 | $1.94K | 0.00% |
| Capital Performance Advisors LLP | 20 | $1.34K | 0.00% |
| Sterling Capital Management LLC | 11 | $736 | 0.00% |
| True Wealth Design, LLC | 7 | $469 | 0.00% |
| Smartleaf Asset Management LLC | 5 | $333 | 0.00% |
| Avion Wealth | 7 | $0 | 0.00% |
Sold out (9)
Institutions that held Utah Medical Products Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Bank of Montreal | 15,559 | $1.33M |
| Quadrature Capital Ltd | 8,521 | $573.8K |
| Invesco Ltd. | 6,650 | $444.3K |
| Penn Mutual Asset Management, LLC | 6,298 | $420.8K |
| Sequoia Financial Advisors, LLC | 4,597 | $307.1K |
| STRS Ohio | 1,000 | $66.8K |
| Loomis Sayles & Co L P | 330 | $22.0K |
| Innealta Capital, LLC | 61 | $4.08K |
| Cornerstone Planning Group LLC | 21 | $1.38K |
Not filed for Q3 2024 yet (1)
Institutions that held Utah Medical Products Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 196,883 | $13.2M |